Aberdeen Group’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $48.9M | Sell |
|
|||||
|
2025
Q2 | $54M | Buy |
|
|||||
|
2025
Q1 | $53.4M | Buy |
|
|||||
|
2024
Q4 | $45.7M | Buy |
|
|||||
|
2024
Q3 | $37.1M | Buy |
|
|||||
|
2024
Q2 | $40.7M | Buy |
|
|||||
|
2024
Q1 | $36.1M | Buy |
|
|||||
|
2023
Q4 | $36.3M | Buy |
|
|||||
|
2023
Q3 | $2.89M | Sell |
|
|||||
|
2023
Q2 | $2.84M | Sell |
|
|||||
|
2023
Q1 | $3.21M | Buy |
|
|||||
|
2022
Q4 | $1.82M | Buy |
|
|||||
|
2022
Q3 | $1.4M | Sell |
|
|||||
|
2022
Q2 | $2.08M | Buy |
|
|||||
|
2022
Q1 | $1.79M | Buy |
|
|||||
|
2021
Q4 | $1.79M | Buy |
|
|||||
|
2021
Q3 | $1.5M | Buy |
|
|||||
|
2021
Q2 | $1.33M | Sell |
|
|||||
|
2021
Q1 | $1.44M | Buy |
|
|||||
|
2020
Q4 | $1.64M | Buy |
|
|||||
|
2020
Q3 | $1.39M | Sell |
|
|||||
|
2020
Q2 | $2.89M | Sell |
|
|||||
|
2020
Q1 | $2.01M | Sell |
|
|||||
|
2019
Q4 | $2.03M | Buy |
|
|||||
|
2019
Q3 | $1.6M | Buy |
|
|||||
|
2019
Q2 | $1.96M | Buy |
|
|||||
|
2019
Q1 | $2.02M | Buy |
|
|||||
|
2018
Q4 | $785K | Sell |
|
|||||
|
2018
Q3 | $916K | Sell |
|
|||||
|
2018
Q2 | $923K | Buy |
|